Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
Neuroimage. 2011 Jan 1;54(1):278-89. doi: 10.1016/j.neuroimage.2010.07.052. Epub 2010 Jul 30.
Measurement of changes in brain cortical thickness is useful for the assessment of regional gray matter atrophy in neurodegenerative conditions. A new longitudinal method, called CLADA (cortical longitudinal atrophy detection algorithm), has been developed for the measurement of changes in cortical thickness in magnetic resonance images (MRI) acquired over time. CLADA creates a subject-specific cortical model which is longitudinally deformed to match images from individual time points. The algorithm was designed to work reliably for lower resolution images, such as the MRIs with 1×1×5 mm(3) voxels previously acquired for many clinical trials in multiple sclerosis (MS). CLADA was evaluated to determine reproducibility, accuracy, and sensitivity. Scan-rescan variability was 0.45% for images with 1mm(3) isotropic voxels and 0.77% for images with 1×1×5 mm(3) voxels. The mean absolute accuracy error was 0.43 mm, as determined by comparison of CLADA measurements to cortical thickness measured directly in post-mortem tissue. CLADA's sensitivity for correctly detecting at least 0.1mm change was 86% in a simulation study. A comparison to FreeSurfer showed good agreement (Pearson correlation=0.73 for global mean thickness). CLADA was also applied to MRIs acquired over 18 months in secondary progressive MS patients who were imaged at two different resolutions. Cortical thinning was detected in this group in both the lower and higher resolution images. CLADA detected a higher rate of cortical thinning in MS patients compared to healthy controls over 2 years. These results show that CLADA can be used for reliable measurement of cortical atrophy in longitudinal studies, even in lower resolution images.
大脑皮质厚度变化的测量对于评估神经退行性疾病中的区域性灰质萎缩很有用。已经开发出一种新的纵向方法,称为 CLADA(皮质纵向萎缩检测算法),用于测量随时间变化的磁共振成像(MRI)中皮质厚度的变化。CLADA 创建了一个特定于主体的皮质模型,该模型会纵向变形以匹配各个时间点的图像。该算法旨在可靠地处理较低分辨率的图像,例如以前在多发性硬化症(MS)的许多临床试验中获取的具有 1×1×5mm(3)体素的 MRI。对 CLADA 进行了评估,以确定其可重复性、准确性和敏感性。具有 1mm(3)各向同性体素的图像的扫描-重扫变异性为 0.45%,而具有 1×1×5mm(3)体素的图像的扫描-重扫变异性为 0.77%。通过将 CLADA 测量值与在死后组织中直接测量的皮质厚度进行比较,确定平均绝对准确性误差为 0.43mm。在模拟研究中,正确检测至少 0.1mm 变化的敏感性为 86%。与 FreeSurfer 的比较显示出良好的一致性(全局平均厚度的 Pearson 相关系数为 0.73)。CLADA 还应用于在两个不同分辨率下成像的二级进展性 MS 患者的 18 个月 MRI。在这组患者中,在较低和较高分辨率的图像中都检测到了皮质变薄。与健康对照组相比,CLADA 在 2 年内检测到 MS 患者的皮质变薄率更高。这些结果表明,CLADA 可用于在纵向研究中可靠地测量皮质萎缩,即使在较低分辨率的图像中也是如此。